We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$84.9B
AUM Growth
+$3.96B
(+4.9%)
Cap. Flow
-$732M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
17.12%
Holding
814
New
62
Increased
269
Reduced
330
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$398M |
| 2 |
Everest Group
EG
|
+$392M |
| 3 |
Verizon
VZ
|
+$364M |
| 4 |
Booking.com
BKNG
|
+$331M |
| 5 |
NetApp
NTAP
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$415M |
| 2 |
Philips
PHG
|
+$332M |
| 3 |
Texas Instruments
TXN
|
+$300M |
| 4 |
GE Aerospace
GE
|
+$283M |
| 5 |
DaVita
DVA
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.58% |
| 2 | Technology | 16.65% |
| 3 | Healthcare | 11.71% |
| 4 | Industrials | 11.38% |
| 5 | Energy | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bank of America
BAC
$428B
| $2.07B | 2.44% |
70,168,924
-1,560,380
| -2% | -$43M |
|
2
JPMorgan Chase
JPM
$942B
| $2.06B | 2.43% |
19,294,570
-551,477
| -3% | -$55.8M |
|
3
Citigroup
C
$223B
| $1.78B | 2.1% |
23,965,600
-625,445
| -3% | -$46.3M |
|
4
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.61B | 1.9% |
8,121,239
+351,872
| +5% | +$66.8M |
|
5
Cisco
CSCO
$442B
| $1.29B | 1.53% |
33,799,233
+3,397,848
| +11% | +$121M |
|
6
TE Connectivity
TEL
$58.8B
| $1.21B | 1.43% |
12,746,402
+318,066
| +3% | +$29.3M |
|
7
DXC Technology
DXC
$1.76B
| $1.2B | 1.41% |
14,630,477
-36,858
| -0.3% | -$2.98M |
|
8
Oracle
ORCL
$438B
| $1.15B | 1.36% |
24,380,374
+455,403
| +2% | +$22.3M |
|
|
ANDV
9
DELISTED
Andeavor
ANDV
| $1.08B | 1.28% |
9,484,915
+1,989,609
| +27% | +$214M |
|
10
Johnson & Johnson
JNJ
$640B
| $1.06B | 1.25% |
7,576,785
+16,723
| +0.2% | +$2.33M |
|
11
Pfizer
PFE
$160B
| $1.04B | 1.23% |
30,347,023
+1,107,672
| +4% | +$37.8M |
|
12
Wells Fargo
WFC
$257B
| $1.04B | 1.22% |
17,117,481
-2,324,657
| -12% | -$131M |
|
13
Merck
MRK
$369B
| $966M | 1.14% |
17,987,692
-1,642,264
| -8% | -$91M |
|
|
DFS
14
DELISTED
Discover Financial Services
DFS
| $938M | 1.11% |
12,199,859
+12,640
| +0.1% | +$870K |
|
15
Allstate
ALL
$65.1B
| $934M | 1.1% |
8,921,194
+215,195
| +2% | +$21.2M |
|
16
Chevron
CVX
$392B
| $915M | 1.08% |
7,306,944
-1,724,489
| -19% | -$204M |
|
17
Flex
FLEX
$42.6B
| $898M | 1.06% |
66,249,610
-6,243,028
| -9% | -$84.4M |
|
18
Diamondback Energy
FANG
$56.1B
| $882M | 1.04% |
6,983,237
-891,192
| -11% | -$96.6M |
|
19
Microsoft
MSFT
$3.75T
| $880M | 1.04% |
10,285,045
-671,781
| -6% | -$55.1M |
|
20
eBay
EBAY
$45.5B
| $860M | 1.01% |
22,788,316
-28,039
| -0.1% | -$1.04M |
|
21
Labcorp
LH
$27.3B
| $840M | 0.99% |
6,127,325
+750,029
| +14% | +$99.1M |
|
22
HP
HPQ
$26.7B
| $822M | 0.97% |
39,146,333
+1,034,661
| +3% | +$22M |
|
23
Elevance Health
ELV
$86.6B
| $752M | 0.89% |
3,342,806
-308,742
| -8% | -$65.8M |
|
24
Chubb
CB
$131B
| $741M | 0.87% |
5,069,708
-282,912
| -5% | -$42.3M |
|
25
Goldman Sachs
GS
$303B
| $740M | 0.87% |
2,903,004
+112,715
| +4% | +$27.6M |
|
Similar funds
Boston Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Boston Partners held 814 positions worth $84.9B, up 4.9% from $80.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2017 filing shows 62 new, 269 increased, 330 reduced and 71 closed positions. Its largest new stake was Everest Group: 1,740,653 shares worth $385M. The largest sale was Abbott, an estimated $415M.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.
- Boston Partners's largest Q4 2017 buy was Everest Group: 1,740,653 shares worth $385M.
- Boston Partners added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $398M increase.
- Boston Partners's biggest Q4 2017 reduction was Abbott, cutting an estimated $415M.
- Boston Partners fully exited Philips in Q4 2017, selling an estimated $332M.
- Boston Partners's ten largest holdings make up 17% of its $84.9B portfolio in Q4 2017.
- Boston Partners opened 62 new positions and closed 71 in Q4 2017.
- Boston Partners's portfolio value rose 4.9% quarter-over-quarter to $84.9B.
Based on Boston Partners's 13F filing for Q4 2017, filed 1 Feb 2018.